ADMA
ADMA Biologics, Inc.NASDAQHealthcare$9.19+0.88%ClosedMarket Cap: $2.19B
As of 2026-04-06
Insider Statistics (Q2 2026)
Purchases
0
Sales
1
Buy/Sell Ratio
0.00
Total Bought
$0.00
Total Sold
$0.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Fri Apr 03 | Kestenberg-Messina Kaitlin M. | officer: COO and SVP, Compliance | Sell | 20,362 | $9.11 | 446,238 |
| Tue Mar 17 | Guiheen Lawrence P. | director | Sell | 30,000 | $0.00 | 105,520 |
| Tue Mar 17 | Grossman Adam S | director, officer: President and CEO | Sell | 15,000 | $5.40 | 2,133,777 |
| Tue Mar 17 | Grossman Adam S | director, officer: President and CEO | Sell | 15,000 | $15.16 | 2,118,777 |
| Tue Mar 17 | Guiheen Lawrence P. | director | Sell | 30,000 | $3.66 | 135,520 |
| Tue Mar 17 | Grossman Adam S | director, officer: President and CEO | Sell | 6,000 | $15.16 | 2,112,777 |
| Tue Mar 10 | Kestenberg-Messina Kaitlin M. | officer: COO and SVP, Compliance | Sell | 4,235 | $15.39 | 557,866 |
| Tue Mar 10 | Kestenberg-Messina Kaitlin M. | officer: COO and SVP, Compliance | Sell | 10,059 | $15.39 | 562,101 |